Pfizer
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Pfizer's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 42% to $58,496,000,000. Profit margin reached 4%. Total operating expenses were $25,450,000,000.
Profit Margin
| 2014 | 49.60B | 9.13B | 18.42% |
|---|---|---|---|
| 2015 | 48.85B | 6.96B | 14.25% |
| 2016 | 52.82B | 7.21B | 13.66% |
| 2017 | 52.54B | 21.30B | 40.55% |
| 2018 | 53.64B | 11.15B | 20.79% |
| 2019 | 51.75B | 16.27B | 31.45% |
| 2020 | 41.90B | 7.02B | 16.75% |
| 2021 | 81.28B | 21.97B | 27.04% |
| 2022 | 100.33B | 31.37B | 31.27% |
| 2023 | 58.49B | 2.11B | 3.62% |
PFE Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 58.49B | 100.33B | 81.28B | 41.90B | 51.75B | 53.64B | 52.54B | 52.82B | 48.85B | 49.60B |
Cost of revenue | 29.68B | 34.34B | 30.82B | 8.69B | 10.21B | 11.24B | 11.24B | 12.32B | 9.64B | 9.57B |
Gross profit | 28.80B | 65.98B | 50.46B | 33.21B | 41.53B | 42.39B | 41.30B | 40.49B | 39.20B | 40.02B |
Operating exp. | ||||||||||
Research and development | 10.67B | 11.42B | 13.82B | 9.40B | 8.65B | 8.00B | 7.65B | 7.87B | 7.69B | 8.39B |
Selling and marketing | 3.7B | 2.8B | 2B | 1.8B | 2.3B | 2.7B | 3.1B | 3.2B | 3.1B | 3.1B |
Total operating expenses | 25.45B | 28.71B | 30.23B | 24.45B | 27.61B | 27.35B | 27.19B | 26.76B | 26.22B | 26.52B |
Operating income | 3.35B | 40.03B | 24.83B | 10.63B | 15.13B | 15.04B | 14.10B | 13.73B | 12.97B | 13.49B |
Other income (expenses), net | -2.30B | -5.30B | -522M | -3.59B | 2.54B | -2.17B | -1.76B | -4.66B | -4.01B | -1.25B |
Income before tax | 1.05B | 34.72B | 24.31B | 7.49B | 17.68B | 11.88B | 12.30B | 8.35B | 8.96B | 12.24B |
Income tax expense | -1.11B | 3.32B | 1.85B | 477M | 1.38B | 706M | -9.04B | 1.12B | 1.99B | 3.12B |
Net income | 2.11B | 31.37B | 21.97B | 7.02B | 16.27B | 11.15B | 21.30B | 7.21B | 6.96B | 9.13B |
Earnings per share | ||||||||||
Basic EPS | 0.38 | 5.59 | 3.95 | 1.26 | 2.92 | 1.9 | 3.57 | 1.18 | 1.13 | 1.44 |
Diluted EPS | 0.37 | 5.47 | 3.88 | 1.25 | 2.87 | 1.87 | 3.52 | 1.17 | 1.11 | 1.42 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |